-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
TUO:F:F- (EUR)
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 15.2Change
+0.20 (+1.33)%Market Cap
USD 23.10BVolume
N/AVerdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 15.2Change
+0.20 (+1.33)%Market Cap
USD 23.10BVolume
N/AVerdict
Verdict
Currency: EUR
Country : Germany
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
IUI1:F | Intuitive Surgical Inc |
N/A |
USD 143.32B |
ESL:F | EssilorLuxottica Société ano.. |
N/A |
USD 95.80B |
ESLC:F | ESSILORLUXOTTICA 1/2/O.N. |
N/A |
USD 93.89B |
BOX:F | Becton Dickinson and Company |
N/A |
USD 64.33B |
HYB0:F | HOYA CORP. ADR/ 1 O.N. |
N/A |
USD 38.45B |
HYB:F | HOYA Corporation |
N/A |
USD 38.30B |
RME:F | ResMed Inc |
N/A |
USD 26.35B |
CBH:F | COLOPLAST SP.ADR 1/10 DK1 |
N/A |
USD 25.53B |
CBHD:F | Coloplast A/S |
N/A |
USD 25.50B |
RMEA:F | Resmed Inc DRC |
N/A |
USD 25.27B |
N/A
Market Performance vs. Industry/Classification (Medical Instruments & Supplies) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 4.83% | 69% | C- | 58% | F | ||
Dividend Return | 151.72% | 91% | A- | 91% | A- | ||
Total Return | 156.55% | 96% | N/A | 95% | A | ||
Trailing 12 Months | |||||||
Capital Gain | 7.04% | 77% | C+ | 57% | F | ||
Dividend Return | 232.39% | 96% | N/A | 90% | A- | ||
Total Return | 239.44% | 98% | N/A | 95% | A | ||
Trailing 5 Years | |||||||
Capital Gain | 17.81% | 61% | D- | 54% | F | ||
Dividend Return | 499.90% | 100% | F | 87% | B+ | ||
Total Return | 517.71% | 100% | F | 91% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 0.82% | 56% | F | 50% | F | ||
Dividend Return | 68.17% | 99% | N/A | 93% | A | ||
Total Return | 67.35% | 100% | F | 93% | A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 74.26% | 8% | B- | 12% | F | ||
Risk Adjusted Return | 91.81% | 98% | N/A | 95% | A | ||
Market Capitalization | 23.10B | 90% | A- | 92% | A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median revenue growth in the previous 5 years compared to its sector